HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Michael Burt Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lieberman, M. D. Articles by Services, t. T. a. G. a. M. T. Search for Related Content PubMed PubMed Citation Articles by Lieberman, M. D. Articles by Services, t. T. a. G. a. M. T.

J Thorac Cardiovasc Surg 1995;109:130-139
© 1995 Mosby, Inc.

GENERAL THORACIC SURGERY

Carcinoma of the esophagus: Prognostic significance of histologic type

New York, N.Y.

From the Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, N.Y.

Address for reprints: Michael Burt, MD, PhD, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021.

Abstract

Previous investigators have reported that in patients with esophageal carcinoma tumor cell type affects prognosis. A retrospective analysis of 258 patients, from 1985 to 1991, undergoing curative esophagogastrectomy for adenocarcinoma (n = 134) or squamous cell carcinoma (n = 124) was performed to test the hypothesis that histologic cell type is an independent prognostic factor and to identify other predictors of survival after resection. The actuarial overall survival (p = 0.16) and disease-specific survival (p = 0.68) were similar for adenocarcinoma (median overall survival = 27 months) and squamous cell carcinoma (median overall survival = 22 months). Univariate analysis identified T stage, N stage, number of diseased nodes, tumor differentiation, tumor site, and blood transfusions as significant (p < 0.05) variables in predicting overall survival. The presence of Barrett's esophagus was not predictive of survival. Multivariate analysis demonstrated that T stage (p = 0.006), N stage (p = 0.01), and number of diseased lymph nodes (p = 0.03) were independent predictors of overall survival. This analysis demonstrated that histologic type is not an independent variable for overall survival in patients undergoing curative esophagogastrectomy for carcinoma of the esophagus and gastroesophageal junction. Outcome is most strongly influenced by extent of disease defined by T and N stage. (J THORAC CARDIOVASC SURG 1995;109:130-9)

This article has been cited by other articles:

				M. Koike, Y. Kodera, Y. Itoh, G. Nakayama, M. Fujiwara, N. Hamajima, and A. Nakao Multivariate Analysis of the Pathologic Features of Esophageal Squamous Cell Cancer: Tumor Budding Is a Significant Independent Prognostic Factor Ann. Surg. Oncol., July 1, 2008; 15(7): 1977 - 1982. [Abstract] [Full Text] [PDF]

				T. J. Kim, K. H. Lee, Y. H. Kim, S. W. Sung, S. Jheon, S.-k. Cho, and K. W. Lee Postoperative Imaging of Esophageal Cancer: What Chest Radiologists Need to Know RadioGraphics, March 1, 2007; 27(2): 409 - 429. [Abstract] [Full Text] [PDF]

				S. M. Lagarde, F. J.W. ten Kate, J. B. Reitsma, O. R.C. Busch, and J. J. B. van Lanschot Prognostic Factors in Adenocarcinoma of the Esophagus or Gastroesophageal Junction J. Clin. Oncol., September 10, 2006; 24(26): 4347 - 4355. [Abstract] [Full Text] [PDF]

				J. Y. Choi, H.-J. Jang, Y. M. Shim, K. Kim, K. S. Lee, K.-H. Lee, Y. Choi, Y. S. Choe, and B.-T. Kim 18F-FDG PET in Patients with Esophageal Squamous Cell Carcinoma Undergoing Curative Surgery: Prognostic Implications J. Nucl. Med., November 1, 2004; 45(11): 1843 - 1850. [Abstract] [Full Text] [PDF]

				K.-T. Kuo, K.-C. Chow, Y.-C. Wu, C.-S. Lin, H.-W. Wang, W.-Y. Li, and L.-S. Wang Clinicopathologic significance of cyclooxygenase-2 overexpression in esophageal squamous cell carcinoma Ann. Thorac. Surg., September 1, 2003; 76(3): 909 - 914. [Abstract] [Full Text] [PDF]

				J. W.C. Entwistle III and M. Goldberg Multimodality therapy for resectable cancer of the thoracic esophagus Ann. Thorac. Surg., March 1, 2002; 73(3): 1009 - 1015. [Abstract] [Full Text] [PDF]

				N. B N Ibrahim ACP Best Practice No. 155. Guidelines for handling oesophageal biopsies and resection specimens and their reporting J. Clin. Pathol., February 1, 2000; 53(2): 89 - 94. [Full Text] [PDF]

				R. J. Korst, V. W. Rusch, E. Venkatraman, M. S. Bains, M. E. Burt, R. J. Downey, and R. J. Ginsberg Proposed Revision Of The Staging Classification For Esophageal Cancer J. Thorac. Cardiovasc. Surg., March 1, 1998; 115(3): 660 - 670. [Abstract] [Full Text]

				S. J. Hoff, J. L. Sawyers, C. D. Blanke, H. Choy, and J. R. Stewart Prognosis of Adenocarcinoma Arising in Barrett's Esophagus Ann. Thorac. Surg., January 1, 1998; 65(1): 176 - 181. [Abstract] [Full Text] [PDF]